We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02922777
Recruitment Status : Active, not recruiting
First Posted : October 4, 2016
Last Update Posted : June 30, 2022
Texas Tech University Health Sciences Center
BerGenBio ASA
Information provided by (Responsible Party):
David E Gerber, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : May 2027